ResearcherCentral South UniversityNo recent work listed

Hongliang Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8085-3876; OpenAlex author ID A5013393140. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper

Papers 1

Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3233/cbm-160655 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiongying Miao · 1 shared paper, 2016 · strength 0.06
- Paper Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. DOI 10.3233/cbm-160655 ↗
Qiong Zou · 1 shared paper, 2016 · strength 0.06
- Paper Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. DOI 10.3233/cbm-160655 ↗
Leping Yang · 1 shared paper, 2016 · strength 0.06
- Paper Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. DOI 10.3233/cbm-160655 ↗
Yuan Yuan Ma · 1 shared paper, 2016 · strength 0.06
- Paper Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. DOI 10.3233/cbm-160655 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.